Featured Research

from universities, journals, and other organizations

Molecule Plays Key Role In Cellular Quality Control Machinery; Findings Carry Implications For Cardiac And Neurological Diseases

Date:
January 10, 2001
Source:
University Of North Carolina School Of Medicine
Summary:
New research at the University of North Carolina at Chapel Hill points to a key role played by a molecular protein in the way body cells maintain quality control when under stress. The findings published this month (January) in Nature Cell Biology add new insights into molecular changes involved in heart attack, heart failure, stroke and some common neurological disorders.

CHAPEL HILL - New research at the University of North Carolina at Chapel Hill points to a key role played by a molecular protein in the way body cells maintain quality control when under stress.

The findings published this month (January) in Nature Cell Biology add new insights into molecular changes involved in heart attack, heart failure, stroke and some common neurological disorders.

They also add important new knowledge to a fundamental biological problem-how do cells decide to deal with proteins with improperly folded structures, whether to spend time and energy trying to fix them or whether to rapidly get rid of them?

"If you have proteins that become misfolded, they do two things. One, they stick together. Two, they accumulate. And this is the bad thing because there are a lot of diseases that we now understand as misfolded protein accumulation," said cardiologist Cam Patterson, MD, associate professor of medicine at UNC-CH School of Medicine and director of the Program in Molecular Cardiology.

"Many of these are neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease-these are all neurological diseases in which the primary pathology is an accumulation of misfolded proteins. But we're now beginning to appreciate that in the heart, under stressful conditions, misfolded proteins also accumulate and that it impairs cardiac function."

In previous research, Patterson and his colleagues sought genes that might regulate the way myocardium (heart muscle) responds to stress. Last year, they were the first to clone the gene CHIP, whose protein apparently blocked the folding activity of other molecules known as heat shock proteins.

Heat shock proteins are known as chaperones. They recognize misfolded proteins and assist in their conversion to a functional form. When cells are stressed, proteins become improperly folded. Heat shock proteins bind to and orchestrate refolding. "Heat shock proteins also make sure the protein ends up in the right place in the cell where it does what it's supposed to do," Patterson explained.

The study team had hypothesized that CHIP might act a kind of check-point in determining whether heat shock proteins try to refold a particular protein or whether the protein should be targeted for degradation, sent to the cellular trash bin for recycling. According to the new study, CHIP is the protein co-chaperone that makes this triage decision. It apparently provides a direct molecular link between the protein folding and degradation pathways.

"Speaking from my perspective of a cardiovascular biologist and cardiologist, this provides us with an entirely new stress-response system to look at, another molecular pathway we can try to modulate to provide protection to cells during conditions where they're being stressed," Patterson said. "We don't know enough about the system to describe exactly how we would modulate it right now. There's a lot more work to be done. We do have a promising pathway, one that's of particular importance for diseases of the myocardium."

This research was supported by the National Heart, Lung and Blood Institute, NIH.


Story Source:

The above story is based on materials provided by University Of North Carolina School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina School Of Medicine. "Molecule Plays Key Role In Cellular Quality Control Machinery; Findings Carry Implications For Cardiac And Neurological Diseases." ScienceDaily. ScienceDaily, 10 January 2001. <www.sciencedaily.com/releases/2001/01/010110074503.htm>.
University Of North Carolina School Of Medicine. (2001, January 10). Molecule Plays Key Role In Cellular Quality Control Machinery; Findings Carry Implications For Cardiac And Neurological Diseases. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2001/01/010110074503.htm
University Of North Carolina School Of Medicine. "Molecule Plays Key Role In Cellular Quality Control Machinery; Findings Carry Implications For Cardiac And Neurological Diseases." ScienceDaily. www.sciencedaily.com/releases/2001/01/010110074503.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins